Sofinnova Investments, Inc. Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$1.7T
Holdings
67
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (67 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANatera | 3,100,560 | $352.0B | 20.29% | |
| 2 | KRTXKaruna Therapeutics, Inc. | 1,952,441 | $222.6B | 12.83% | |
| 3 | AVTEAerovate Therapeutics, Inc. | 3,758,686 | $85.8B | 4.95% | |
| 4 | YMABUSDY-mAbs Therapeutics, Inc | 2,194,278 | $74.2B | 4.27% | |
| 5 | ASNDAscendis Pharma A/S | 521,923 | $68.7B | 3.96% | |
| 6 | AZNAstraZeneca PLC | 959,632 | $57.5B | 3.31% | |
| 7 | AQLTiShares TR | 325,000 | $53.2B | 3.07% | Put |
| 8 | BOLT1EURBolt Biotherapeutics, Inc. | 2,754,437 | $42.6B | 2.45% | |
| 9 | UTHUnited Therapeutics Corp | 216,085 | $38.8B | 2.23% | |
| 10 | VERAVera Therapeutics, Inc. | 2,914,776 | $38.6B | 2.23% | |
| 11 | BIIBBiogen Inc | 110,600 | $38.3B | 2.21% | |
| 12 | INZYInozyme Pharma, Inc. | 2,028,308 | $34.6B | 1.99% | |
| 13 | GRTXGalera Therapeutics, Inc | 3,083,712 | $30.3B | 1.75% | |
| 14 | XLRNAcceleron Pharma Inc | 233,638 | $29.3B | 1.69% | |
| 15 | AFWAlign Technology Inc | 47,093 | $28.8B | 1.66% | |
| 16 | PTCTPTC Therapeutics Inc | 581,940 | $24.6B | 1.42% | |
| 17 | IM8NInsmed Inc | 844,169 | $24.0B | 1.38% | |
| 18 | SRPTSarepta Therapeutics, Inc. | 298,500 | $23.2B | 1.34% | |
| 19 | ARKTARK ETF TR | 250,000 | $23.1B | 1.33% | Put |
| 20 | HRTXHeron Therapeutics Inc | 1,467,675 | $22.8B | 1.31% | |
| 21 | —Checkmate Pharmaceuticals Inc | 3,606,707 | $21.5B | 1.24% | |
| 22 | NXTCNextcure, Inc | 2,671,856 | $21.5B | 1.24% | |
| 23 | PTGXProtagonist Therapeutics Inc | 449,082 | $20.2B | 1.16% | |
| 24 | NBIXNeurocrine Biosciences, Inc. | 203,200 | $19.8B | 1.14% | |
| 25 | EX9Exelixis Inc | 1,079,681 | $19.7B | 1.13% | |
| 26 | —Akouos, Inc | 1,515,074 | $19.0B | 1.10% | |
| 27 | PODDInsulet Corp | 68,500 | $18.8B | 1.08% | |
| 28 | VRTXVertex Pharmaceuticals Inc | 88,214 | $17.8B | 1.03% | |
| 29 | RGNXRegenxbio Inc | 427,740 | $16.6B | 0.96% | |
| 30 | —Nucana Biomed Ltd | 5,599,999 | $15.5B | 0.89% | |
| 31 | AGENEURAgenus Inc | 2,769,900 | $15.2B | 0.88% | |
| 32 | DC4Dexcom Inc | 33,713 | $14.4B | 0.83% | |
| 33 | —ObsEva SA | 4,749,623 | $14.4B | 0.83% | |
| 34 | ITCIEURIntra-Cellular Therapies Inc | 313,159 | $12.8B | 0.74% | |
| 35 | MRTXEURMirati Therapeutics Inc | 78,538 | $12.7B | 0.73% | |
| 36 | AGIOAgios Pharmaceuticals, Inc. | 219,033 | $12.1B | 0.70% | |
| 37 | RETAEURReata Pharmaceuticals Inc | 79,601 | $11.3B | 0.65% | |
| 38 | QUREUniqure NV | 324,303 | $10.0B | 0.58% | |
| 39 | AMGNAmgen Inc | 40,500 | $9.9B | 0.57% | |
| 40 | CYTKCytokinetics Inc | 481,323 | $9.5B | 0.55% | |
| 41 | KURAKura Oncology Inc | 444,372 | $9.3B | 0.53% | |
| 42 | —Nucana Biomed Ltd | 2,400,000 | $6.6B | 0.38% | |
| 43 | MGNXMacroGenics Inc | 234,504 | $6.3B | 0.36% | |
| 44 | CCXIEURChemoCentryx Inc | 465,637 | $6.2B | 0.36% | |
| 45 | MRNS*Marinus Pharmaceuticals Inc | 346,160 | $6.2B | 0.36% | |
| 46 | CHRSCoherus BioSciences | 434,555 | $6.0B | 0.35% | |
| 47 | CYTCyteir Therapeutics, Inc. | 265,000 | $5.7B | 0.33% | |
| 48 | —FibroGen, Inc. | 200,000 | $5.3B | 0.31% | Put |
| 49 | IMTXImmatics NV | 443,370 | $5.1B | 0.30% | |
| 50 | AMRNAmarin Corp | 1,170,584 | $5.1B | 0.30% | |
| 51 | —TCR2 Therapeutics Inc | 296,282 | $4.9B | 0.28% | |
| 52 | TCE2Celldex Therapeutics, Inc. | 134,724 | $4.5B | 0.26% | |
| 53 | MIRMMirum Pharmaceuticals Inc | 259,465 | $4.5B | 0.26% | |
| 54 | JNCEEURJounce Therapeutics Inc | 624,756 | $4.2B | 0.24% | |
| 55 | FATEFate Therapeutics Inc | 46,386 | $4.0B | 0.23% | |
| 56 | ALGSAligos Therapeutics Inc | 164,051 | $3.3B | 0.19% | |
| 57 | —ChemoCentryx Inc | 215,000 | $2.9B | 0.17% | Call |
| 58 | OTICEUROtonomy Inc | 1,251,256 | $2.8B | 0.16% | |
| 59 | REPLReplimune Group Inc | 71,661 | $2.8B | 0.16% | |
| 60 | BCRXBioCryst Pharmaceuticals Inc | 158,609 | $2.5B | 0.14% | |
| 61 | ACADACADIA Pharmaceuticals Inc | 100,000 | $2.4B | 0.14% | Call |
| 62 | —TCR2 Therapeutics Inc | 139,700 | $2.3B | 0.13% | Put |
| 63 | —Synlogic Inc. | 574,972 | $2.2B | 0.13% | |
| 64 | YB4PSavara Inc | 1,278,424 | $2.2B | 0.13% | |
| 65 | PDSBPDS Biotechnology Corporation | 142,635 | $1.8B | 0.10% | |
| 66 | CTIC1USDCTI BioPharma Corp | 171,619 | $429.0M | 0.02% | |
| 67 | —Sierra Oncology, Inc. | 2,500 | $49.0M | 0.00% |